ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

Biomarkers are the only feasible way to detect and monitor presymptomatic Alzheimer's disease (AD). No single biomarker can predict future cognitive decline with an acceptable level of accuracy. In addition to designing powerful multimodal diagnostic platforms, a careful investigation of the ma...

Full description

Bibliographic Details
Main Authors: Liana G. Apostolova, Kristy S. Hwang, Omid Kohannim, David Avila, David Elashoff, Clifford R. Jack, Jr., Leslie Shaw, John Q. Trojanowski, Michael W. Weiner, Paul M. Thompson
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:NeuroImage: Clinical
Subjects:
Alzheimer's disease
Abeta
Tau
Hippocampus atrophy
ADNI
Diagnosis
Online Access:http://www.sciencedirect.com/science/article/pii/S221315821300171X

Similar Items

Similar Items